Trade-Ideas LLC identified




) as a strong and under the radar candidate. In addition to specific proprietary factors, Trade-Ideas identified Exponent as such a stock due to the following factors:

  • EXPO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $5.7 million.
  • EXPO has traded 2.596999999999999975131004248396493494510650634765625 options contracts today.
  • EXPO is making at least a new 3-day high.
  • EXPO has a PE ratio of 31.
  • EXPO is mentioned 1.19 times per day on StockTwits.
  • EXPO has not yet been mentioned on StockTwits today.
  • EXPO is currently in the upper 20% of its 1-year range.
  • EXPO is in the upper 35% of its 20-day range.
  • EXPO is in the upper 45% of its 5-day range.
  • EXPO is currently trading above yesterday's high.

'Strong and Under the Radar' stocks tend to be worthwhile stocks to watch for a variety of factors including historical back testing and price action. Market technicians refer to such stocks as being in an accumulation phase before a mark-up and peak. Traders and hedge funds have frequently found that these types of stocks continue to build a solid price base and then ultimately spike higher and peak when others 'discover' how good the stock is performing. By leveraging the social discovery aspect of StockTwits we are highlighting stocks that don't currently receive much attention from retail investors, but we suspect may soon garner more attention.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in EXPO with the Ticky from Trade-Ideas. See the FREE profile for EXPO NOW at Trade-Ideas

More details on EXPO:

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific; and Environmental and Health. The stock currently has a dividend yield of 1.3%. EXPO has a PE ratio of 31. Currently there are no analysts that rate Exponent a buy, no analysts rate it a sell, and 2 rate it a hold.

The average volume for Exponent has been 94,900 shares per day over the past 30 days. Exponent has a market cap of $1.4 billion and is part of the services sector and diversified services industry. The stock has a beta of 0.98 and a short float of 2.5% with 5.80 days to cover. Shares are up 9.9% year-to-date as of the close of trading on Tuesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.


TheStreet Quant Ratings

rates Exponent as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow.

Highlights from the ratings report include:

  • Powered by its strong earnings growth of 49.33% and other important driving factors, this stock has surged by 26.84% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the stock's future course, although almost any stock can fall in a broad market decline, EXPO should continue to move higher despite the fact that it has already enjoyed a very nice gain in the past year.
  • EXPONENT INC has improved earnings per share by 49.3% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, EXPONENT INC increased its bottom line by earning $1.60 versus $1.48 in the prior year. This year, the market expects an improvement in earnings ($1.84 versus $1.60).
  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Professional Services industry. The net income increased by 48.5% when compared to the same quarter one year prior, rising from $10.33 million to $15.35 million.
  • Despite its growing revenue, the company underperformed as compared with the industry average of 5.1%. Since the same quarter one year prior, revenues slightly increased by 3.6%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • EXPO has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign. Along with this, the company maintains a quick ratio of 4.57, which clearly demonstrates the ability to cover short-term cash needs.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.